Neurocrine Biosciences, Inc. (LON: 0K6R)
London
· Delayed Price · Currency is GBP · Price in USD 152.89
-0.89 (-0.58%)
Jan 31, 2025, 7:14 PM BST
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of 12.37 billion as of January 31, 2025. Its market cap has increased by 16.26% in one year.
Market Cap
12.37B
Enterprise Value
11.61B
Revenue
1.67B
Ranking
n/a
PE Ratio
42.95
Stock Price
152.89
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 136.97M to 12.37B, an increase of 8,928.65%. That is a compound annual growth rate of 16.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.43B |
| GSK plc | 57.15B |
| Haleon | 34.01B |
| Smith & Nephew | 9.00B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 5.05B |
| HUTCHMED (China) | 1.89B |
| Oxford Nanopore Technologies | 1.36B |